ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.
Title: | ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis. |
---|---|
Authors: | Suzuki, Junya1 (AUTHOR) suzukij@naramed-u.ac.jp, Namisaki, Tadashi1 (AUTHOR) htky@naramed-u.ac.jp, Takya, Hiroaki1 (AUTHOR) kajik@naramed-u.ac.jp, Kaji, Kosuke1 (AUTHOR) a-shibamoto@naramed-u.ac.jp, Nishimura, Norihisa1 (AUTHOR) asahei@naramed-u.ac.jp, Shibamoto, Akihiko1 (AUTHOR) kubotaka@naramed-u.ac.jp, Asada, Shohei1 (AUTHOR) satoshi181@naramed-u.ac.jp, Kubo, Takahiro1 (AUTHOR) tomooka@naramed-u.ac.jp, Iwai, Satoshi1 (AUTHOR) souitit@naramed-u.ac.jp, Tomooka, Fumimasa1 (AUTHOR) yuring0309@naramed-u.ac.jp, Takeda, Soichi1 (AUTHOR) mtanaka@naramed-u.ac.jp, Koizumi, Aritoshi1 (AUTHOR) takuya@naramed-u.ac.jp, Tanaka, Misako1 (AUTHOR) yukifuji@naramed-u.ac.jp, Matsuda, Takuya1 (AUTHOR) tsujih@naramed-u.ac.jp, Inoue, Takashi2 (AUTHOR) tkinoue0@naramed-u.ac.jp, Fujimoto, Yuki1 (AUTHOR) fujinaga@naramed-u.ac.jp, Tsuji, Yuki1 (AUTHOR) shinyasato@naramed-u.ac.jp, Fujinaga, Yukihisa1 (AUTHOR) kawara@naramed-u.ac.jp, Sato, Shinya1 (AUTHOR) stakemi@naramed-u.ac.jp, Kitagawa, Koh1 (AUTHOR) mitoroak@naramed-u.ac.jp |
Source: | International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2678. 13p. |
Subject Terms: | *PORTAL vein, *JAPANESE people, *SPIRAL computed tomography, *CIRRHOSIS of the liver, *FIBRIN fibrinogen degradation products, *FIBRIN |
Abstract: | Portal vein thrombosis (PVT), one of the most prevalent hepatic vascular conditions in patients with liver cirrhosis (LC), is associated with high mortality rates. An imbalance between a disintegrin-like metalloproteinase with thrombospondin type-1 motifs 13 (ADAMTS-13) enzyme and von Willebrand factor (VWF) is responsible for hypercoagulability, including spontaneous thrombus formation in blood vessels. Herein, we aimed to identify potential prognostic and diagnostic biomarkers in Japanese patients with LC and PVT. In total, 345 patients were divided into two groups: 40 patients who developed PVT (PVT group) and 305 who did not develop PVT (NPVT group). Among the 345 patients with LC, 81% (279/345) were deemed ineligible due to the presence of preventive comorbidities, active or recent malignancies, and organ dysfunction. The remaining 66 patients were divided into two groups: the PVT group (n = 33) and the NPVT group (n = 33). Plasma ADAMTS-13 activity (ADAMTS-13:AC) and the vWF antigen (VWF:Ag) were measured using enzyme-linked immunosorbent assays. Contrast-enhanced, three-dimensional helical computed tomography (CT) was used to detect and characterize PVT. ADAMTS-13:AC was significantly lower in the PVT group than in the NPVT group. No significant differences in plasma vWF:Ag or liver stiffness were observed between the two groups. ADAMTS-13:AC of <18.8 was an independent risk factor for PVT on multivariate analyses (odds ratio: 1.67, 95% confidence interval: 1.21–3.00, p < 0.002). The receiver operating characteristic analysis of ADAMTS-13:AC revealed an area under the curve of 0.913 in PVT detection. Patients with PVT having ADAMTS-13:AC ≥18.8 (n = 17) had higher albumin levels and better prognoses than those with ADAMTS-13:AC <18.8 (n = 16). No significant correlations of ADAMTS-13:AC levels with either fibrin degradation product or D-dimer levels were observed. ADAMTS-13:AC levels could be potential diagnostic and prognostic biomarkers for PVT in Japanese patients with LC. [ABSTRACT FROM AUTHOR] |
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
Database: | Academic Search Complete |
Full text is not displayed to guests. | Login for full access. |
FullText | Links: – Type: pdflink Text: Availability: 1 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=16616596&ISBN=&volume=25&issue=5&date=20240301&spage=2678&pages=2678-2690&title=International Journal of Molecular Sciences&atitle=ADAMTS-13%3A%20A%20Prognostic%20Biomarker%20for%20Portal%20Vein%20Thrombosis%20in%20Japanese%20Patients%20with%20Liver%20Cirrhosis.&aulast=Suzuki%2C%20Junya&id=DOI:10.3390/ijms25052678 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: a9h DbLabel: Academic Search Complete An: 175994821 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Suzuki%2C+Junya%22">Suzuki, Junya</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> suzukij@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Namisaki%2C+Tadashi%22">Namisaki, Tadashi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> htky@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Takya%2C+Hiroaki%22">Takya, Hiroaki</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> kajik@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Kaji%2C+Kosuke%22">Kaji, Kosuke</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> a-shibamoto@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Nishimura%2C+Norihisa%22">Nishimura, Norihisa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> asahei@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Shibamoto%2C+Akihiko%22">Shibamoto, Akihiko</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> kubotaka@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Asada%2C+Shohei%22">Asada, Shohei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> satoshi181@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Kubo%2C+Takahiro%22">Kubo, Takahiro</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> tomooka@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Iwai%2C+Satoshi%22">Iwai, Satoshi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> souitit@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Tomooka%2C+Fumimasa%22">Tomooka, Fumimasa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yuring0309@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Takeda%2C+Soichi%22">Takeda, Soichi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> mtanaka@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Koizumi%2C+Aritoshi%22">Koizumi, Aritoshi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> takuya@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Tanaka%2C+Misako%22">Tanaka, Misako</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yukifuji@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Matsuda%2C+Takuya%22">Matsuda, Takuya</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> tsujih@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Inoue%2C+Takashi%22">Inoue, Takashi</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> tkinoue0@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Fujimoto%2C+Yuki%22">Fujimoto, Yuki</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> fujinaga@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Tsuji%2C+Yuki%22">Tsuji, Yuki</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> shinyasato@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Fujinaga%2C+Yukihisa%22">Fujinaga, Yukihisa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> kawara@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Sato%2C+Shinya%22">Sato, Shinya</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> stakemi@naramed-u.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Kitagawa%2C+Koh%22">Kitagawa, Koh</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> mitoroak@naramed-u.ac.jp</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Molecular+Sciences%22">International Journal of Molecular Sciences</searchLink>. Mar2024, Vol. 25 Issue 5, p2678. 13p. – Name: Subject Label: Subject Terms Group: Su Data: *<searchLink fieldCode="DE" term="%22PORTAL+vein%22">PORTAL vein</searchLink><br />*<searchLink fieldCode="DE" term="%22JAPANESE+people%22">JAPANESE people</searchLink><br />*<searchLink fieldCode="DE" term="%22SPIRAL+computed+tomography%22">SPIRAL computed tomography</searchLink><br />*<searchLink fieldCode="DE" term="%22CIRRHOSIS+of+the+liver%22">CIRRHOSIS of the liver</searchLink><br />*<searchLink fieldCode="DE" term="%22FIBRIN+fibrinogen+degradation+products%22">FIBRIN fibrinogen degradation products</searchLink><br />*<searchLink fieldCode="DE" term="%22FIBRIN%22">FIBRIN</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Portal vein thrombosis (PVT), one of the most prevalent hepatic vascular conditions in patients with liver cirrhosis (LC), is associated with high mortality rates. An imbalance between a disintegrin-like metalloproteinase with thrombospondin type-1 motifs 13 (ADAMTS-13) enzyme and von Willebrand factor (VWF) is responsible for hypercoagulability, including spontaneous thrombus formation in blood vessels. Herein, we aimed to identify potential prognostic and diagnostic biomarkers in Japanese patients with LC and PVT. In total, 345 patients were divided into two groups: 40 patients who developed PVT (PVT group) and 305 who did not develop PVT (NPVT group). Among the 345 patients with LC, 81% (279/345) were deemed ineligible due to the presence of preventive comorbidities, active or recent malignancies, and organ dysfunction. The remaining 66 patients were divided into two groups: the PVT group (n = 33) and the NPVT group (n = 33). Plasma ADAMTS-13 activity (ADAMTS-13:AC) and the vWF antigen (VWF:Ag) were measured using enzyme-linked immunosorbent assays. Contrast-enhanced, three-dimensional helical computed tomography (CT) was used to detect and characterize PVT. ADAMTS-13:AC was significantly lower in the PVT group than in the NPVT group. No significant differences in plasma vWF:Ag or liver stiffness were observed between the two groups. ADAMTS-13:AC of <18.8 was an independent risk factor for PVT on multivariate analyses (odds ratio: 1.67, 95% confidence interval: 1.21–3.00, p < 0.002). The receiver operating characteristic analysis of ADAMTS-13:AC revealed an area under the curve of 0.913 in PVT detection. Patients with PVT having ADAMTS-13:AC ≥18.8 (n = 17) had higher albumin levels and better prognoses than those with ADAMTS-13:AC <18.8 (n = 16). No significant correlations of ADAMTS-13:AC levels with either fibrin degradation product or D-dimer levels were observed. ADAMTS-13:AC levels could be potential diagnostic and prognostic biomarkers for PVT in Japanese patients with LC. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=175994821 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ijms25052678 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 2678 Subjects: – SubjectFull: PORTAL vein Type: general – SubjectFull: JAPANESE people Type: general – SubjectFull: SPIRAL computed tomography Type: general – SubjectFull: CIRRHOSIS of the liver Type: general – SubjectFull: FIBRIN fibrinogen degradation products Type: general – SubjectFull: FIBRIN Type: general Titles: – TitleFull: ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Suzuki, Junya – PersonEntity: Name: NameFull: Namisaki, Tadashi – PersonEntity: Name: NameFull: Takya, Hiroaki – PersonEntity: Name: NameFull: Kaji, Kosuke – PersonEntity: Name: NameFull: Nishimura, Norihisa – PersonEntity: Name: NameFull: Shibamoto, Akihiko – PersonEntity: Name: NameFull: Asada, Shohei – PersonEntity: Name: NameFull: Kubo, Takahiro – PersonEntity: Name: NameFull: Iwai, Satoshi – PersonEntity: Name: NameFull: Tomooka, Fumimasa – PersonEntity: Name: NameFull: Takeda, Soichi – PersonEntity: Name: NameFull: Koizumi, Aritoshi – PersonEntity: Name: NameFull: Tanaka, Misako – PersonEntity: Name: NameFull: Matsuda, Takuya – PersonEntity: Name: NameFull: Inoue, Takashi – PersonEntity: Name: NameFull: Fujimoto, Yuki – PersonEntity: Name: NameFull: Tsuji, Yuki – PersonEntity: Name: NameFull: Fujinaga, Yukihisa – PersonEntity: Name: NameFull: Sato, Shinya – PersonEntity: Name: NameFull: Kitagawa, Koh IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 16616596 Numbering: – Type: volume Value: 25 – Type: issue Value: 5 Titles: – TitleFull: International Journal of Molecular Sciences Type: main |
ResultId | 1 |